News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Yakup Ergün: NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing
Jan 8, 2025, 12:00

Yakup Ergün: NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:

“NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing

Pleural effusion cfDNA NGS achieved an 88% mutation detection rate, outperforming cell pellet Sanger sequencing (78%) and clinical tissue testing (66%).”

Yakup Ergün: NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing

Enhanced Detection of Actionable Mutations in NSCLC Through Pleural Effusion Cell-Free DNA Sequencing: A Prospective Study

Authors: Hsin-Yi Wang et al.

Yakup Ergün: NSCLC Mutation Detection via Pleural Effusion cfDNA Sequencing

cancer Chao-Chi Ho Chia-Lin Hsu Ching-Yao Yang Hsin-Yi Wang James Chih-Hsin Yang Jin-Yuan Shih OncoDaily Oncology Shang-Gin Wu Wei-Yu Liao Yen-Ting Lin
Special Coverage
Blog
Apr 19, 2025, 21:04
Jasmine Kamboj Hosts Policy Webinar with Expert Panel on May 2
Blog
Apr 19, 2025, 20:48
Palliative Care Knowledge in ICUs: Bilal Awad Publishes Q1 Research
Blog
Apr 19, 2025, 20:25
Breast Density Reporting Urged by Lobular Ireland Founder Siobhan Freeney
Blog
Apr 19, 2025, 20:05
Suzette DiMascio: I reflect on a moment that changed my life - and helped save another
Blog
Apr 19, 2025, 19:36
Pranati Yadlapalli Presents Nerve Injury Research at National Conference
Blog
Apr 19, 2025, 19:17
Yelak Biru: Rahul Banerjee on redefining 'cure' in myeloma
Science
Apr 19, 2025, 19:01
Stephen Liu: Perspective on unintended consequences of patient portal access
Blog
Apr 19, 2025, 18:46
Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing
Blog
Apr 19, 2025, 18:42
Pediatric Exercise Oncology Conference 2026: Save the Date - FORTEe
Insight
Apr 19, 2025, 18:29
ESMO living guidelines on metastatic breast cancer
Blog
Apr 19, 2025, 18:20
Todd Davis: Ligand Pharmaceuticals announces agreement to combine Pelthos with Channel Therapeutics
Blog
Apr 19, 2025, 18:05
Prasad Raj Dandekar: A detailed conversation about immunotherapy with Sewanti Limaye